Akademik Veri Yönetim Sistemi
Interdisciplinary Cancer Research, Nima Rezaei, Editör, Springer, London/Berlin , Edinburgh, ss.471-490, 2025
A new era in drug delivery systems has been brought about by nanotechnology, which provides answers to problems caused by active chemicals that are insoluble in water. The resulting paradigm change improves targeted system improvements and site-specificity, which leads to quicker and more efficient clinical results. Advancements in diagnostics rely heavily on small materials, which help medical imaging methods become more specific. The synthesis of bio-structures requires robust nanomaterials, such as biosensors, composites, metabolic stimuli-responsive systems, antibacterial materials, and antifungal materials. Pharmaceuticals designed with nanotechnology have higher efficacies and are used in genetic testing, tissue regeneration, injectable devices, and cell-based research. One notable area where nanotechnology is revolutionizing healthcare is in cancer treatments, where it allows for more effective treatment through targeted drug delivery and controlled release. The evolution of drug delivery systems, from polymer-drug conjugates to liposomes and metal nanoparticles, demonstrates continuous innovation. In parallel, nanoparticles have significantly improved chemotherapy by accumulating in tumor areas, thereby enhancing the efficiency of drug delivery. In this chapter, the focus is on the targeted precision provided by advanced drug delivery techniques made possible by nanotechnology, which lowers side effects and enhances patient outcomes. Large-surface-area inorganic structures, along with both metallic and non-metallic nanoparticles, showcase the diverse range of applications for nanotechnology in nanocarriers.